Evidence map›Paper›PMID 40433380›Full record

ArticleFrontiers in immunology2025

Diego Catalán, Lilian Soto, Óscar Neira, María C Cuéllar-Gutiérrez, Roberto Díaz-Peña, Octavio Aravena, Eduard Palou, Montserrat Carrascal, Juan C Aguillón, Jaxaira Maggi

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Diego CatalánImmune Regulation and Tolerance Research Group (IRT Group), Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Lilian SotoImmune Regulation and Tolerance Research Group (IRT Group), Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Óscar NeiraHospital del Salvador, Universidad de Chile, Santiago, Chile.
María C Cuéllar-GutiérrezHospital del Salvador, Universidad de Chile, Santiago, Chile.
Roberto Díaz-PeñaFacultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile.
Octavio AravenaImmune Regulation and Tolerance Research Group (IRT Group), Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Eduard PalouServicio de Inmunología, Hospital Clínic de Barcelona, Barcelona, Spain.
Montserrat CarrascalBiological and Environmental Proteomics Group, Institute of Biomedical Research of Barcelona, Spanish National Research Council (IIBB-CSIC/IDIBAPS), Barcelona, Spain.
Juan C AguillónImmune Regulation and Tolerance Research Group (IRT Group), Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Jaxaira MaggiBiological and Environmental Proteomics Group, Institute of Biomedical Research of Barcelona, Spanish National Research Council (IIBB-CSIC/IDIBAPS), Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Rheumatoid arthritis (RA) is an autoimmune disease influenced by genetic factors, particularly Methods: We genotyped 367 RA patients and 623 HC for Results: The most frequent SE alleles among RA patients were * Discussion: This study provides a comprehensive overview of

Indexed as

AllelesArthritis, RheumatoidGenetic Predisposition to DiseaseHLA-DRB1 ChainsAdultAgedAnti-Citrullinated Protein AntibodiesAutoantibodiesCase-Control StudiesChileFemaleGene FrequencyGenotypeHumansMaleMiddle AgedAnti-Citrullinated Protein AntibodiesAutoantibodiesHLA-DRB1 Chainsanti-CCP antibodiesChilean cohortHLA-DRB1 allelesrheumatoid arthritisshared epitope

Identifiers

PMID40433380
PMCPMC12106328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.